HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC) ...Middle East

SINGAPORE, Jan. 24, 2021 /PRNewswire/ -- HistoIndex's stain-free AI digital pathology platform, incorporating Second Harmonic Generation (SHG), holds promise as a quantitative tool in the assessment of morphological and architectural changes in collagen fibers within the tumor-stromal...

Hence then, the article about histoindex explores the clinical utility of stain free ai digital pathology platform in 388 patients with triple negative breast cancer tnbc was published today ( Monday 25/01/2021 - 01:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC) )

Also on site :

• Former Rangers Defenseman, 13-Year NHL Veteran Ab DeMarco Jr. Dies
• '80s Music Legend Was a 'Secret Philanthropist' and Gave Away Millions
• Chris Evert Shares a Heartbreaking Update About Her Cancer Journey